Jaypirca 50 mg
Jaypirca 50 mg is a medicine authorised by Swissmedic under authorisation number 68733. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 November 2023 and the authorisation is limited until 22 September 2030. ATC code L01EL places the medicine in the group Antineoplastic agents.
| Authorisation number | 68733 |
|---|---|
| Name | Jaypirca 50 mg |
| Full name | Jaypirca 50 mg, comprimés pelliculés |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EL |
| First authorisation | 30 November 2023 |
| Authorisation validity | 22 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Jaypirca 50 mg, comprimés pelliculés | A | 30 November 2023 |
| 2 | Jaypirca 100 mg, comprimés pelliculés | A | 30 November 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | L01EL | 07.16.1. | A |
| 4 | 28 | Tablette(n) | L01EL | 07.16.1. | A |
| 2 | 30 | Tablette(n) | L01EL | 07.16.1. | A |
| 3 | 60 | Tablette(n) | L01EL | 07.16.1. | A |
| 5 | 28 | Tablette(n) | L01EL | 07.16.1. | A |
| 6 | 56 | Tablette(n) | L01EL | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Jaypirca 50 mg authorised in Switzerland?
Yes. Jaypirca 50 mg is authorised by Swissmedic under authorisation number 68733, data as of 01 September 2026. The authorisation is limited until 22 September 2030.
Which dispensing category does Jaypirca 50 mg have?
Jaypirca 50 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Jaypirca 50 mg?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.